Kuwait’s healthcare and pharmaceuticals industries are small compared to some of its regional neighbors and are dominated by high levels of government expenditure, and a robust, free public healthcare service for indigenous residents.

Increasing wealth, overstretched public services and a majority expatriate population has upped demand for the high quality of service and imported pharmaceuticals that only the private sector can supply. The government, eager to cut costs, has been steadily shaping a healthcare development plan and has explicitly called upon private investors to participate.